| New insights into the genetic etiology of Alzheimer’s disease and related dementias C Bellenguez, F Küçükali, IE Jansen, L Kleineidam, S Moreno-Grau, ... Nature genetics 54 (4), 412-436, 2022 | 866 | 2022 |
| Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores I De Rojas, S Moreno-Grau, N Tesi, B Grenier-Boley, V Andrade, ... Nature communications 12 (1), 3417, 2021 | 173 | 2021 |
| Genome‐wide association analysis of dementia and its clinical endophenotypes reveal novel loci associated with Alzheimer's disease and three causality networks: the GR@ ACE project S Moreno‐Grau, I De Rojas, I Hernández, I Quintela, L Montrreal, ... Alzheimer's & Dementia 15 (10), 1333-1347, 2019 | 133 | 2019 |
| New insights on the genetic etiology of Alzheimer’s and related dementia C Bellenguez, F Küçükali, I Jansen, V Andrade, S Moreno-Grau, N Amin, ... MedRxiv, 2020.10. 01.20200659, 2020 | 71 | 2020 |
| Neuropsychiatric profiles and conversion to dementia in mild cognitive impairment, a latent class analysis N Roberto, MJ Portella, M Marquié, M Alegret, I Hernández, A Mauleón, ... Scientific reports 11 (1), 6448, 2021 | 49 | 2021 |
| Correlations between plasma and PET beta-amyloid levels in individuals with subjective cognitive decline: the Fundació ACE Healthy Brain Initiative (FACEHBI) I de Rojas, J Romero, O Rodriguez-Gomez, P Pesini, A Sanabria, ... Alzheimer's research & therapy 10, 1-12, 2018 | 44 | 2018 |
| Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers IE Jansen, SJ van der Lee, D Gomez-Fonseca, I de Rojas, MC Dalmasso, ... Acta Neuropathologica 144 (5), 821-842, 2022 | 40 | 2022 |
| Association between retinal thickness and β-amyloid brain accumulation in individuals with subjective cognitive decline: Fundació ACE Healthy Brain Initiative M Marquié, S Valero, M Castilla-Marti, J Martínez, O Rodríguez-Gómez, ... Alzheimer's research & therapy 12, 1-14, 2020 | 32 | 2020 |
| The MAPT H1 Haplotype Is a Risk Factor for Alzheimer’s Disease in APOE ε4 Non-carriers P Sánchez-Juan, S Moreno, I de Rojas, I Hernández, S Valero, M Alegret, ... Frontiers in Aging Neuroscience 11, 327, 2019 | 31 | 2019 |
| Common variants in Alzheimer’s disease: Novel association of six genetic variants with AD and risk stratification by polygenic risk scores I de Rojas, S Moreno-Grau, N Tesi, B Grenier-Boley, V Andrade, I Jansen, ... medRxiv, 19012021, 2019 | 22 | 2019 |
| Interaction of neuropsychiatric symptoms with APOE ε4 and conversion to dementia in MCI patients in a Memory Clinic S Valero, M Marquié, I De Rojas, A Espinosa, S Moreno-Grau, A Orellana, ... Scientific Reports 10 (1), 20058, 2020 | 18* | 2020 |
| Establishing In-House cutoffs of csf alzheimer’s disease biomarkers for the AT (N) stratification of the Alzheimer center barcelona cohort A Orellana, P García-González, S Valero, L Montrreal, I de Rojas, ... International Journal of Molecular Sciences 23 (13), 6891, 2022 | 16 | 2022 |
| Matrix metalloproteinase 10 is linked to the risk of progression to dementia of the Alzheimer’s type PV Martino Adami, A Orellana, P García, L Kleineidam, E Alarcón-Martín, ... Brain 145 (7), 2507-2517, 2022 | 15 | 2022 |
| Exploring genetic associations of Alzheimer’s disease loci with mild cognitive impairment neurocognitive endophenotypes A Espinosa, B Hernández-Olasagarre, S Moreno-Grau, L Kleineidam, ... Frontiers in aging neuroscience 10, 340, 2018 | 15 | 2018 |
| Analysis of psychological symptoms following disclosure of amyloid–positron emission tomography imaging results to adults with subjective cognitive decline C Caprioglio, F Ribaldi, LNC Visser, C Minguillon, LE Collij, ... JAMA network open 6 (1), e2250921-e2250921, 2023 | 11 | 2023 |
| A randomized, open-label clinical trial in mild cognitive impairment with EGb 761 examining blood markers of inflammation and oxidative stress X Morató, M Marquié, JP Tartari, A Lafuente, C Abdelnour, M Alegret, ... Scientific Reports 13 (1), 5406, 2023 | 10 | 2023 |
| Neuropsychiatric profile as a predictor of cognitive decline in mild cognitive impairment N Roberto, MJ Portella, M Marquié, M Alegret, I Hernández, A Mauleón, ... Frontiers in aging neuroscience 13, 718949, 2021 | 10 | 2021 |
| Automatized FACEmemory® scoring is related to Alzheimer’s disease phenotype and biomarkers in early-onset mild cognitive impairment: The BIOFACE cohort M Alegret, O Sotolongo-Grau, EE de Antonio, A Pérez-Cordón, A Orellana, ... Alzheimer's Research & Therapy 14 (1), 43, 2022 | 9 | 2022 |
| Long runs of homozygosity are associated with Alzheimer’s disease S Moreno-Grau, MV Fernández, I De Rojas, P Garcia-González, ... Translational psychiatry 11 (1), 142, 2021 | 9 | 2021 |
| clinical effect of early vs late amyloid positron emission tomography in memory clinic patients: the AMYPAD-DPMS randomized clinical trial D Altomare, F Barkhof, C Caprioglio, LE Collij, P Scheltens, IL Alves, ... JAMA neurology 80 (6), 548-557, 2023 | 7 | 2023 |
